No Picture
Boston Cambridge Biotech Trending News

Children and their caregivers in ‘low-opportunity neighborhoods’ face increased risk of early death

April 7, 2023—Children in low-opportunity neighborhoods—where employment options are few, transportation is unreliable, and crime and poverty rates are high—face an increased risk of premature death and of experiencing the premature death of a caregiver, […]

No Picture
Boston Cambridge Biotech Trending News

STAT+: Brazilian committee says a Vertex cystic fibrosis is not cost-effective and should not be reimbursed

A Brazilian government advisory committee recommended that the health ministry not pay for a cystic fibrosis treatment made by Vertex Pharmaceuticals after deciding the drug is not cost effective, the latest clash over access to […]

No Picture
Boston Cambridge Biotech Trending News

U.S. Neurologists Cautiously Optimistic Following Accelerated Approval and Launch of Eisai/Biogen’s Leqembi for Early Alzheimer’s Disease, According to Spherix Global Insights

Concerns about ARIA and the associated monitoring requirements for Leqembi could present significant barriers to uptake. EXTON, Pa., April 5, 2023 /PRNewswire/ — With the accelerated approval on January 6, 2023 for early Alzheimer’s disease, […]

No Picture
Boston Cambridge Biotech Trending News

ConcertAI Releases CTO 2.0, a Next Generation AI SaaS Solution for Oncology Clinical Trial Design and Optimization

CAMBRIDGE, Mass., April 5, 2023 /PRNewswire/ — ConcertAI, LLC (ConcertAI), a leader in AI Software-as-a-Service (SaaS) technology and Real-world Evidence (RWE) solutions for life sciences and healthcare, today announced the release of its next generation […]

No Picture
Boston Cambridge Biotech Trending News

‘If we don’t, others will’: White House Covid adviser calls on doctors to combat a vacuum of medical information

WALTHAM, Mass. — The coordinator of the Biden administration’s Covid-19 response team called on doctors to take a leadership role with patients to battle medical misinformation and disinformation, linking the continuing death toll in part […]

No Picture
Boston Cambridge Biotech Trending News

Chiesi Global Rare Diseases Announces Approval of FERRIPROX™ MR Deferiprone Extended-Release Tablets in Canada

New formulation allows twice-daily dosing in patients with transfusional iron overload due to thalassemia syndromes when current chelation therapy is inadequate, or sickle cell disease or other anemias. BOSTON, March 31, 2023 /PRNewswire/ — Chiesi […]

No Picture
Boston Cambridge Biotech Trending News

Speeding up drug discovery with diffusion generative models

With the release of platforms like DALL-E 2 and Midjourney, diffusion generative models have achieved mainstream popularity, owing to their ability to generate a series of absurd, breathtaking, and often meme-worthy images from text prompts […]

No Picture
Boston Cambridge Biotech Trending News

A shot in the arm

Biologics, a class of therapeutics derived from living organisms, offer enormous advantages to patients battling challenging diseases and disorders. Treatments based on biologics can boost the immune system to stem attacks from infections or target […]